Basket cover image
17 handpicked stocks

True Innovators

These aren't just companies—they're the architects of tomorrow's markets. Each stock has been carefully selected by our expert analysts for their ability to create entirely new industries, setting the standards that followers must imitate.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+7

Author avatar

Han Tan | Market Analyst

Updated 3 days ago | Published at juin 17

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

AAPL

Apple, Inc.

AAPL

Current price

$230.56

A quintessential innovator that redefined personal computing, mobile phones, and digital music distribution.

GOOGL

Alphabet Inc (Google)

GOOGL

Current price

$201.57

Pioneered search engine technology and now leads in AI, autonomous driving, and digital advertising platforms.

AMZN

Amazon.com Inc.

AMZN

Current price

$228.01

Transformed retail with its e-commerce platform and created the cloud computing market with Amazon Web Services.

About This Group of Stocks

1

Our Expert Thinking

We've focused on companies that don't just participate in markets—they create them. These pioneering firms invent transformative technologies and business models that competitors are forced to follow, from smartphones to streaming services to cloud computing.

2

What You Need to Know

These market-makers typically benefit from substantial growth potential as they secure early market share, build powerful brand loyalty, and define industry standards. Many are currently positioned to capitalize on AI commercialization and technological sovereignty trends.

3

Why These Stocks

Each company was selected based on their proven history of disruptive innovation, significant R&D investments, and robust intellectual property portfolios. They represent the foundational players that are actively shaping future economic landscapes.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+36.50%

Group Performance Snapshot

36.5%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 36.5% over the next year.

14 of 17

Stocks Rated Buy by Analysts

14 of 17 assets in this group are rated Buy by professional analysts.

1.4%

Group Growth

This group averaged a 1.4% return last month.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

💡

They Create Markets, Not Follow Them

These aren't just successful companies—they're the originators that establish entirely new categories others rush to imitate. Getting in early with true innovators could mean capturing growth at its source.

🚀

AI Revolution Supercharging Innovation

The commercialization of artificial intelligence is creating a perfect environment for these innovators to extend their lead. Many are positioned to launch next-generation products that could reshape their industries.

🔮

Tomorrow's Economy, Today

These companies aren't just part of the future—they're actively creating it. By investing in the architects of tomorrow's markets, you're potentially securing a front-row seat to where the economy is heading.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

The New Cost of Compliance: Investing in HR Tech

The New Cost of Compliance: Investing in HR Tech

Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.

View stocks
GLP-1s Target Liver Disease

GLP-1s Target Liver Disease

The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.

View stocks
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

View stocks
View All

Frequently Asked Questions

Everything you need to know about the product and billing.